nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—brain cancer	0.0428	0.132	CbGeAlD
Nedocromil—HSP90AA1—pineal body—brain cancer	0.0306	0.0944	CbGeAlD
Nedocromil—HSP90AA1—ganglion—brain cancer	0.0219	0.0678	CbGeAlD
Nedocromil—HSP90AA1—endothelium—brain cancer	0.0189	0.0584	CbGeAlD
Nedocromil—HSP90AA1—blood vessel—brain cancer	0.0175	0.0539	CbGeAlD
Nedocromil—HSP90AA1—hindbrain—brain cancer	0.0166	0.0514	CbGeAlD
Nedocromil—FPR1—endocrine gland—brain cancer	0.0147	0.0455	CbGeAlD
Nedocromil—FPR1—head—brain cancer	0.0145	0.0449	CbGeAlD
Nedocromil—PTGDR—head—brain cancer	0.0137	0.0424	CbGeAlD
Nedocromil—FPR1—central nervous system—brain cancer	0.0133	0.041	CbGeAlD
Nedocromil—PTGDR—central nervous system—brain cancer	0.0125	0.0387	CbGeAlD
Nedocromil—PTGDR—brain—brain cancer	0.00995	0.0307	CbGeAlD
Nedocromil—HSP90AA1—brainstem—brain cancer	0.00954	0.0295	CbGeAlD
Nedocromil—HSP90AA1—telencephalon—brain cancer	0.00847	0.0261	CbGeAlD
Nedocromil—HSP90AA1—gonad—brain cancer	0.00707	0.0218	CbGeAlD
Nedocromil—HSP90AA1—pituitary gland—brain cancer	0.00689	0.0213	CbGeAlD
Nedocromil—Disorder sight—Temozolomide—brain cancer	0.00687	0.0381	CcSEcCtD
Nedocromil—HSP90AA1—medulla oblongata—brain cancer	0.00665	0.0205	CbGeAlD
Nedocromil—Dysphonia—Procarbazine—brain cancer	0.00658	0.0364	CcSEcCtD
Nedocromil—CYSLTR1—endocrine gland—brain cancer	0.00615	0.019	CbGeAlD
Nedocromil—HSP90AA1—midbrain—brain cancer	0.00608	0.0188	CbGeAlD
Nedocromil—CYSLTR1—head—brain cancer	0.00608	0.0188	CbGeAlD
Nedocromil—HSP90AA1—spinal cord—brain cancer	0.00593	0.0183	CbGeAlD
Nedocromil—CYSLTR1—central nervous system—brain cancer	0.00555	0.0171	CbGeAlD
Nedocromil—HSP90AA1—endocrine gland—brain cancer	0.00534	0.0165	CbGeAlD
Nedocromil—HSP90AA1—head—brain cancer	0.00527	0.0163	CbGeAlD
Nedocromil—Photophobia—Procarbazine—brain cancer	0.00508	0.0281	CcSEcCtD
Nedocromil—HSP90AA1—central nervous system—brain cancer	0.00481	0.0149	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—brain cancer	0.0047	0.0145	CbGeAlD
Nedocromil—CYSLTR1—brain—brain cancer	0.0044	0.0136	CbGeAlD
Nedocromil—Otitis media—Temozolomide—brain cancer	0.0042	0.0233	CcSEcCtD
Nedocromil—Visual impairment—Lomustine—brain cancer	0.00413	0.0228	CcSEcCtD
Nedocromil—HSP90AA1—brain—brain cancer	0.00382	0.0118	CbGeAlD
Nedocromil—Viral infection—Temozolomide—brain cancer	0.00362	0.0201	CcSEcCtD
Nedocromil—Eosinophilia—Procarbazine—brain cancer	0.00336	0.0186	CcSEcCtD
Nedocromil—Leukopenia—Lomustine—brain cancer	0.00334	0.0185	CcSEcCtD
Nedocromil—Pneumonia—Procarbazine—brain cancer	0.00304	0.0169	CcSEcCtD
Nedocromil—Pain—Carboplatin—brain cancer	0.00297	0.0165	CcSEcCtD
Nedocromil—Ear pain—Temozolomide—brain cancer	0.00278	0.0154	CcSEcCtD
Nedocromil—Body temperature increased—Carboplatin—brain cancer	0.00275	0.0152	CcSEcCtD
Nedocromil—Gastroenteritis—Temozolomide—brain cancer	0.00268	0.0148	CcSEcCtD
Nedocromil—Nasal congestion—Temozolomide—brain cancer	0.00261	0.0144	CcSEcCtD
Nedocromil—Body temperature increased—Lomustine—brain cancer	0.0024	0.0133	CcSEcCtD
Nedocromil—Tremor—Procarbazine—brain cancer	0.00222	0.0123	CcSEcCtD
Nedocromil—Leukopenia—Procarbazine—brain cancer	0.00212	0.0117	CcSEcCtD
Nedocromil—Cough—Procarbazine—brain cancer	0.00206	0.0114	CcSEcCtD
Nedocromil—Bronchitis—Temozolomide—brain cancer	0.00197	0.0109	CcSEcCtD
Nedocromil—Dry mouth—Procarbazine—brain cancer	0.00197	0.0109	CcSEcCtD
Nedocromil—Vomiting—Lomustine—brain cancer	0.00193	0.0107	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Temozolomide—brain cancer	0.00191	0.0106	CcSEcCtD
Nedocromil—Pneumonia—Carmustine—brain cancer	0.00191	0.0105	CcSEcCtD
Nedocromil—Pneumonia—Temozolomide—brain cancer	0.00184	0.0102	CcSEcCtD
Nedocromil—Nausea—Lomustine—brain cancer	0.00181	0.01	CcSEcCtD
Nedocromil—Sinusitis—Temozolomide—brain cancer	0.00172	0.00951	CcSEcCtD
Nedocromil—Fatigue—Procarbazine—brain cancer	0.00166	0.00922	CcSEcCtD
Nedocromil—Pain—Procarbazine—brain cancer	0.00165	0.00914	CcSEcCtD
Nedocromil—Leukopenia—Hydroxyurea—brain cancer	0.00164	0.00908	CcSEcCtD
Nedocromil—Visual impairment—Carmustine—brain cancer	0.00164	0.00907	CcSEcCtD
Nedocromil—Pharyngitis—Temozolomide—brain cancer	0.00163	0.00903	CcSEcCtD
Nedocromil—Visual impairment—Temozolomide—brain cancer	0.00158	0.00877	CcSEcCtD
Nedocromil—Gastrointestinal pain—Procarbazine—brain cancer	0.00158	0.00874	CcSEcCtD
Nedocromil—Urticaria—Procarbazine—brain cancer	0.00153	0.00849	CcSEcCtD
Nedocromil—Abdominal pain—Procarbazine—brain cancer	0.00153	0.00845	CcSEcCtD
Nedocromil—Body temperature increased—Procarbazine—brain cancer	0.00153	0.00845	CcSEcCtD
Nedocromil—Pneumonia—Etoposide—brain cancer	0.00147	0.00816	CcSEcCtD
Nedocromil—Hypersensitivity—Procarbazine—brain cancer	0.00142	0.00788	CcSEcCtD
Nedocromil—Dysgeusia—Temozolomide—brain cancer	0.0014	0.00776	CcSEcCtD
Nedocromil—Tremor—Carmustine—brain cancer	0.00139	0.00768	CcSEcCtD
Nedocromil—Asthenia—Procarbazine—brain cancer	0.00139	0.00767	CcSEcCtD
Nedocromil—Tremor—Temozolomide—brain cancer	0.00134	0.00742	CcSEcCtD
Nedocromil—Dyspnoea—Hydroxyurea—brain cancer	0.00133	0.00738	CcSEcCtD
Nedocromil—Leukopenia—Carmustine—brain cancer	0.00132	0.00734	CcSEcCtD
Nedocromil—Diarrhoea—Procarbazine—brain cancer	0.00132	0.00732	CcSEcCtD
Nedocromil—Dyspepsia—Hydroxyurea—brain cancer	0.00132	0.00728	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00129	0.00714	CcSEcCtD
Nedocromil—Fatigue—Hydroxyurea—brain cancer	0.00129	0.00713	CcSEcCtD
Nedocromil—Leukopenia—Temozolomide—brain cancer	0.00128	0.00709	CcSEcCtD
Nedocromil—Pain—Hydroxyurea—brain cancer	0.00128	0.00708	CcSEcCtD
Nedocromil—Dizziness—Procarbazine—brain cancer	0.00128	0.00707	CcSEcCtD
Nedocromil—Chest pain—Carmustine—brain cancer	0.00126	0.00698	CcSEcCtD
Nedocromil—Cough—Temozolomide—brain cancer	0.00125	0.00691	CcSEcCtD
Nedocromil—Vomiting—Procarbazine—brain cancer	0.00123	0.0068	CcSEcCtD
Nedocromil—Rash—Procarbazine—brain cancer	0.00122	0.00674	CcSEcCtD
Nedocromil—Dermatitis—Procarbazine—brain cancer	0.00122	0.00674	CcSEcCtD
Nedocromil—Headache—Procarbazine—brain cancer	0.00121	0.0067	CcSEcCtD
Nedocromil—Dry mouth—Temozolomide—brain cancer	0.00119	0.0066	CcSEcCtD
Nedocromil—Body temperature increased—Hydroxyurea—brain cancer	0.00118	0.00654	CcSEcCtD
Nedocromil—Anaphylactic shock—Temozolomide—brain cancer	0.00117	0.00646	CcSEcCtD
Nedocromil—Nausea—Procarbazine—brain cancer	0.00115	0.00635	CcSEcCtD
Nedocromil—Dysgeusia—Etoposide—brain cancer	0.00112	0.00621	CcSEcCtD
Nedocromil—Hypersensitivity—Hydroxyurea—brain cancer	0.0011	0.0061	CcSEcCtD
Nedocromil—Dyspnoea—Carmustine—brain cancer	0.00108	0.00596	CcSEcCtD
Nedocromil—Asthenia—Hydroxyurea—brain cancer	0.00107	0.00594	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Carmustine—brain cancer	0.00104	0.00578	CcSEcCtD
Nedocromil—Dyspnoea—Temozolomide—brain cancer	0.00104	0.00576	CcSEcCtD
Nedocromil—Pain—Carmustine—brain cancer	0.00103	0.00572	CcSEcCtD
Nedocromil—Dyspepsia—Temozolomide—brain cancer	0.00103	0.00569	CcSEcCtD
Nedocromil—Leukopenia—Etoposide—brain cancer	0.00102	0.00567	CcSEcCtD
Nedocromil—Diarrhoea—Hydroxyurea—brain cancer	0.00102	0.00566	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Temozolomide—brain cancer	0.00101	0.00558	CcSEcCtD
Nedocromil—Fatigue—Temozolomide—brain cancer	0.00101	0.00557	CcSEcCtD
Nedocromil—Cough—Etoposide—brain cancer	0.000999	0.00553	CcSEcCtD
Nedocromil—Pain—Temozolomide—brain cancer	0.000998	0.00553	CcSEcCtD
Nedocromil—Dizziness—Hydroxyurea—brain cancer	0.000988	0.00547	CcSEcCtD
Nedocromil—Gastrointestinal pain—Carmustine—brain cancer	0.000988	0.00547	CcSEcCtD
Nedocromil—Chest pain—Etoposide—brain cancer	0.000974	0.0054	CcSEcCtD
Nedocromil—Abdominal pain—Carmustine—brain cancer	0.000955	0.00529	CcSEcCtD
Nedocromil—Body temperature increased—Carmustine—brain cancer	0.000955	0.00529	CcSEcCtD
Nedocromil—Gastrointestinal pain—Temozolomide—brain cancer	0.000955	0.00529	CcSEcCtD
Nedocromil—Vomiting—Hydroxyurea—brain cancer	0.00095	0.00526	CcSEcCtD
Nedocromil—Rash—Hydroxyurea—brain cancer	0.000942	0.00522	CcSEcCtD
Nedocromil—Dermatitis—Hydroxyurea—brain cancer	0.000941	0.00521	CcSEcCtD
Nedocromil—Headache—Hydroxyurea—brain cancer	0.000936	0.00518	CcSEcCtD
Nedocromil—Anaphylactic shock—Etoposide—brain cancer	0.000934	0.00517	CcSEcCtD
Nedocromil—Urticaria—Temozolomide—brain cancer	0.000927	0.00514	CcSEcCtD
Nedocromil—Body temperature increased—Temozolomide—brain cancer	0.000923	0.00511	CcSEcCtD
Nedocromil—Abdominal pain—Temozolomide—brain cancer	0.000923	0.00511	CcSEcCtD
Nedocromil—Hypersensitivity—Carmustine—brain cancer	0.00089	0.00493	CcSEcCtD
Nedocromil—Nausea—Hydroxyurea—brain cancer	0.000888	0.00492	CcSEcCtD
Nedocromil—Asthenia—Carmustine—brain cancer	0.000867	0.0048	CcSEcCtD
Nedocromil—Hypersensitivity—Temozolomide—brain cancer	0.00086	0.00476	CcSEcCtD
Nedocromil—Asthenia—Temozolomide—brain cancer	0.000838	0.00464	CcSEcCtD
Nedocromil—Dyspnoea—Etoposide—brain cancer	0.000833	0.00461	CcSEcCtD
Nedocromil—Diarrhoea—Carmustine—brain cancer	0.000826	0.00458	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Etoposide—brain cancer	0.000806	0.00447	CcSEcCtD
Nedocromil—Fatigue—Etoposide—brain cancer	0.000805	0.00446	CcSEcCtD
Nedocromil—Dizziness—Carmustine—brain cancer	0.000799	0.00442	CcSEcCtD
Nedocromil—Pain—Etoposide—brain cancer	0.000799	0.00442	CcSEcCtD
Nedocromil—Diarrhoea—Temozolomide—brain cancer	0.000799	0.00442	CcSEcCtD
Nedocromil—Dizziness—Temozolomide—brain cancer	0.000772	0.00427	CcSEcCtD
Nedocromil—Vomiting—Carmustine—brain cancer	0.000768	0.00425	CcSEcCtD
Nedocromil—Gastrointestinal pain—Etoposide—brain cancer	0.000764	0.00423	CcSEcCtD
Nedocromil—Rash—Carmustine—brain cancer	0.000762	0.00422	CcSEcCtD
Nedocromil—Dermatitis—Carmustine—brain cancer	0.000761	0.00421	CcSEcCtD
Nedocromil—Headache—Carmustine—brain cancer	0.000757	0.00419	CcSEcCtD
Nedocromil—Vomiting—Temozolomide—brain cancer	0.000742	0.00411	CcSEcCtD
Nedocromil—Urticaria—Etoposide—brain cancer	0.000742	0.00411	CcSEcCtD
Nedocromil—Body temperature increased—Etoposide—brain cancer	0.000738	0.00409	CcSEcCtD
Nedocromil—Abdominal pain—Etoposide—brain cancer	0.000738	0.00409	CcSEcCtD
Nedocromil—Rash—Temozolomide—brain cancer	0.000736	0.00408	CcSEcCtD
Nedocromil—Dermatitis—Temozolomide—brain cancer	0.000735	0.00407	CcSEcCtD
Nedocromil—Headache—Temozolomide—brain cancer	0.000731	0.00405	CcSEcCtD
Nedocromil—Nausea—Carmustine—brain cancer	0.000718	0.00397	CcSEcCtD
Nedocromil—Nausea—Temozolomide—brain cancer	0.000693	0.00384	CcSEcCtD
Nedocromil—Hypersensitivity—Etoposide—brain cancer	0.000688	0.00381	CcSEcCtD
Nedocromil—Asthenia—Etoposide—brain cancer	0.00067	0.00371	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—GLI2—brain cancer	0.000668	0.00135	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—SKP2—brain cancer	0.000667	0.00135	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000656	0.00132	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—TRPC6—brain cancer	0.000655	0.00132	CbGpPWpGaD
Nedocromil—Diarrhoea—Etoposide—brain cancer	0.000639	0.00354	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—VEGFA—brain cancer	0.000634	0.00128	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GLI1—brain cancer	0.000628	0.00127	CbGpPWpGaD
Nedocromil—Dizziness—Etoposide—brain cancer	0.000618	0.00342	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—VAV1—brain cancer	0.000612	0.00123	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTCH2—brain cancer	0.000611	0.00123	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.00061	0.00123	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HES5—brain cancer	0.000607	0.00122	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SHH—brain cancer	0.000599	0.00121	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—VEGFA—brain cancer	0.000598	0.00121	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—SKP2—brain cancer	0.000596	0.0012	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SUFU—brain cancer	0.000595	0.0012	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDK6—brain cancer	0.000594	0.0012	CbGpPWpGaD
Nedocromil—Vomiting—Etoposide—brain cancer	0.000594	0.00329	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—brain cancer	0.000592	0.0012	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HES5—brain cancer	0.000592	0.00119	CbGpPWpGaD
Nedocromil—Rash—Etoposide—brain cancer	0.000589	0.00326	CcSEcCtD
Nedocromil—Dermatitis—Etoposide—brain cancer	0.000588	0.00326	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—ERBB2—brain cancer	0.000588	0.00119	CbGpPWpGaD
Nedocromil—Headache—Etoposide—brain cancer	0.000585	0.00324	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—DTX2—brain cancer	0.000579	0.00117	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SHH—brain cancer	0.000579	0.00117	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TRPC6—brain cancer	0.000578	0.00117	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STRADA—brain cancer	0.000575	0.00116	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GFAP—brain cancer	0.000575	0.00116	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PTCH1—brain cancer	0.000568	0.00115	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SMO—brain cancer	0.000568	0.00115	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—TRPC6—brain cancer	0.000566	0.00114	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TRPC6—brain cancer	0.000558	0.00113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—VAV1—brain cancer	0.000555	0.00112	CbGpPWpGaD
Nedocromil—Nausea—Etoposide—brain cancer	0.000555	0.00307	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—PTCH1—brain cancer	0.000549	0.00111	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SMO—brain cancer	0.000549	0.00111	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDK4—brain cancer	0.000547	0.0011	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HEY1—brain cancer	0.000545	0.0011	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.00054	0.00109	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—DLL1—brain cancer	0.000534	0.00108	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—SHH—brain cancer	0.000533	0.00108	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDK6—brain cancer	0.000531	0.00107	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—TRPC6—brain cancer	0.000514	0.00104	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000512	0.00103	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PTCH1—brain cancer	0.000505	0.00102	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—SMO—brain cancer	0.000505	0.00102	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—PIK3CG—brain cancer	0.000495	0.000999	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ABR—brain cancer	0.000479	0.000968	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2C9—brain cancer	0.000468	0.000943	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—PIK3CG—brain cancer	0.000465	0.000939	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GLI2—brain cancer	0.000463	0.000934	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000455	0.000917	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SHH—brain cancer	0.000454	0.000916	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOTCH2—brain cancer	0.000454	0.000916	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—PIK3CG—brain cancer	0.000449	0.000907	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000448	0.000903	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOTCH2—brain cancer	0.000439	0.000885	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTCH2—brain cancer	0.000439	0.000885	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TRPC6—brain cancer	0.000438	0.000884	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GLI1—brain cancer	0.000435	0.000879	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—VAV1—brain cancer	0.000433	0.000875	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VAV1—brain cancer	0.000433	0.000874	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTCH1—brain cancer	0.000431	0.000869	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SMO—brain cancer	0.000431	0.000869	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HES5—brain cancer	0.000425	0.000857	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—VAV1—brain cancer	0.000424	0.000856	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HES1—brain cancer	0.000422	0.000852	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VAV1—brain cancer	0.000418	0.000844	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN2A—brain cancer	0.000418	0.000843	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—BRCA2—brain cancer	0.000413	0.000834	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SUFU—brain cancer	0.000413	0.000833	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STRADA—brain cancer	0.000412	0.000832	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IDH1—brain cancer	0.000408	0.000824	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—brain cancer	0.000407	0.000822	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—RELA—brain cancer	0.000402	0.000811	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCNE1—brain cancer	0.0004	0.000808	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GFAP—brain cancer	0.000398	0.000804	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—BSG—brain cancer	0.000398	0.000802	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—PCNA—brain cancer	0.000397	0.0008	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CG—brain cancer	0.000388	0.000784	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HEY1—brain cancer	0.000387	0.000781	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—VAV1—brain cancer	0.000385	0.000777	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—DLL1—brain cancer	0.000379	0.000766	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HEY1—brain cancer	0.000378	0.000762	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000375	0.000756	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HES1—brain cancer	0.000372	0.000751	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—DLL1—brain cancer	0.00037	0.000747	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—IL2—brain cancer	0.000361	0.000728	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HES1—brain cancer	0.00036	0.000726	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PDGFRA—brain cancer	0.000355	0.000716	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—PCNA—brain cancer	0.000355	0.000716	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PDGFRA—brain cancer	0.000355	0.000715	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CG—brain cancer	0.000353	0.000712	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—brain cancer	0.000348	0.000703	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SPP1—brain cancer	0.000344	0.000695	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ABR—brain cancer	0.000344	0.000695	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOTCH2—brain cancer	0.000344	0.000695	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDK4—brain cancer	0.000343	0.000692	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PDGFRA—brain cancer	0.000342	0.000691	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—IDH1—brain cancer	0.000342	0.00069	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ERBB2—brain cancer	0.000339	0.000684	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SPP1—brain cancer	0.000332	0.000671	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GLI2—brain cancer	0.000332	0.000671	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SKP2—brain cancer	0.000331	0.000669	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CDK4—brain cancer	0.000331	0.000668	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VAV1—brain cancer	0.000328	0.000662	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—IL2—brain cancer	0.000327	0.000661	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ENO2—brain cancer	0.000323	0.000651	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SHH—brain cancer	0.000323	0.000651	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL2—brain cancer	0.000316	0.000638	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SHH—brain cancer	0.000315	0.000635	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GLI1—brain cancer	0.000313	0.000631	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—IRS2—brain cancer	0.000312	0.000629	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IRS2—brain cancer	0.000311	0.000628	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—VEGFA—brain cancer	0.000308	0.000621	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDK4—brain cancer	0.000307	0.000619	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—STAT3—brain cancer	0.000305	0.000615	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TRPC6—brain cancer	0.000304	0.000613	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IRS2—brain cancer	0.000301	0.000607	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTCH1—brain cancer	0.000298	0.000602	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SMO—brain cancer	0.000298	0.000602	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SUFU—brain cancer	0.000296	0.000598	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GFAP—brain cancer	0.000286	0.000577	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HES1—brain cancer	0.000282	0.000569	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—APC—brain cancer	0.000275	0.000555	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CG—brain cancer	0.000275	0.000555	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—brain cancer	0.000273	0.000551	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HEY1—brain cancer	0.000271	0.000547	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ENO2—brain cancer	0.00027	0.000545	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CG—brain cancer	0.000269	0.000543	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PDGFRA—brain cancer	0.000269	0.000542	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—DLL1—brain cancer	0.000266	0.000536	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—APC—brain cancer	0.000265	0.000536	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CG—brain cancer	0.000265	0.000536	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000262	0.000529	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—brain cancer	0.000261	0.000527	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SPP1—brain cancer	0.000261	0.000526	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—VAV1—brain cancer	0.000252	0.00051	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—brain cancer	0.00025	0.000505	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—brain cancer	0.000248	0.000501	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CG—brain cancer	0.000244	0.000493	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—RELA—brain cancer	0.000244	0.000491	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ERBB2—brain cancer	0.000242	0.000488	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—brain cancer	0.000242	0.000488	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH2—brain cancer	0.000239	0.000481	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IRS2—brain cancer	0.000236	0.000476	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—brain cancer	0.000235	0.000474	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN2A—brain cancer	0.000234	0.000473	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—VAV1—brain cancer	0.000233	0.00047	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—brain cancer	0.000232	0.000469	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VAV1—brain cancer	0.000227	0.000459	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SHH—brain cancer	0.000226	0.000456	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—brain cancer	0.000221	0.000447	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TRPC6—brain cancer	0.000218	0.00044	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—RELA—brain cancer	0.000215	0.000434	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—RELA—brain cancer	0.000215	0.000433	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SMO—brain cancer	0.000214	0.000432	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTCH1—brain cancer	0.000214	0.000432	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ERBB2—brain cancer	0.000214	0.000431	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ERBB2—brain cancer	0.000213	0.000431	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CTNNB1—brain cancer	0.000212	0.000427	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CG—brain cancer	0.000208	0.00042	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—APC—brain cancer	0.000208	0.00042	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—RELA—brain cancer	0.000207	0.000419	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PDGFRA—brain cancer	0.000207	0.000417	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ERBB2—brain cancer	0.000206	0.000416	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HES1—brain cancer	0.0002	0.000405	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—brain cancer	0.000198	0.000399	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HES1—brain cancer	0.000196	0.000395	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—brain cancer	0.000193	0.00039	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PDGFRA—brain cancer	0.000191	0.000385	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—brain cancer	0.00019	0.000383	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—brain cancer	0.000189	0.000382	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—brain cancer	0.000189	0.000381	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTNNB1—brain cancer	0.000187	0.000377	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—brain cancer	0.000187	0.000377	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CTNNB1—brain cancer	0.000187	0.000377	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—brain cancer	0.000186	0.000376	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDGFRA—brain cancer	0.000186	0.000376	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—STAT3—brain cancer	0.000185	0.000372	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—brain cancer	0.000182	0.000368	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IRS2—brain cancer	0.000182	0.000366	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SPP1—brain cancer	0.000181	0.000365	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CTNNB1—brain cancer	0.00018	0.000364	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—brain cancer	0.000178	0.000358	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—brain cancer	0.000172	0.000347	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH2—brain cancer	0.000171	0.000346	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—brain cancer	0.000168	0.000338	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—IRS2—brain cancer	0.000168	0.000338	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—brain cancer	0.000164	0.000332	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IRS2—brain cancer	0.000164	0.00033	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VAV1—brain cancer	0.000163	0.000329	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—RELA—brain cancer	0.000163	0.000328	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—STAT3—brain cancer	0.000163	0.000328	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB2—brain cancer	0.000162	0.000326	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—brain cancer	0.000159	0.00032	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—brain cancer	0.000159	0.00032	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—STAT3—brain cancer	0.000157	0.000317	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—brain cancer	0.000151	0.000305	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—brain cancer	0.000148	0.000299	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—APC—brain cancer	0.000148	0.000299	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—brain cancer	0.000148	0.000299	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—brain cancer	0.000147	0.000296	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—brain cancer	0.000146	0.000295	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—APC—brain cancer	0.000144	0.000291	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CG—brain cancer	0.000144	0.000291	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—brain cancer	0.000143	0.000288	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—brain cancer	0.000143	0.000288	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CTNNB1—brain cancer	0.000142	0.000286	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HES1—brain cancer	0.00014	0.000283	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDGFRA—brain cancer	0.000134	0.00027	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—brain cancer	0.000132	0.000265	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—brain cancer	0.00013	0.000263	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SPP1—brain cancer	0.00013	0.000262	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—RELA—brain cancer	0.000125	0.000253	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—brain cancer	0.000125	0.000251	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB2—brain cancer	0.000124	0.000251	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—brain cancer	0.000124	0.000251	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CG—brain cancer	0.000124	0.00025	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—STAT3—brain cancer	0.000123	0.000249	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—brain cancer	0.00012	0.000242	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IRS2—brain cancer	0.000117	0.000237	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB2—brain cancer	0.000115	0.000232	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—brain cancer	0.000115	0.000231	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—RELA—brain cancer	0.000113	0.000228	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—brain cancer	0.000113	0.000228	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB2—brain cancer	0.000112	0.000226	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—brain cancer	0.000112	0.000226	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTNNB1—brain cancer	0.000109	0.00022	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CG—brain cancer	0.000104	0.000209	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—APC—brain cancer	0.000104	0.000209	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—brain cancer	0.000102	0.000205	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CTNNB1—brain cancer	0.000101	0.000203	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—brain cancer	9.91e-05	0.0002	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CTNNB1—brain cancer	9.81e-05	0.000198	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—STAT3—brain cancer	9.49e-05	0.000192	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—brain cancer	9.41e-05	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—STAT3—brain cancer	8.76e-05	0.000177	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—brain cancer	8.64e-05	0.000174	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—brain cancer	8.63e-05	0.000174	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—STAT3—brain cancer	8.55e-05	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—brain cancer	8.14e-05	0.000164	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—RELA—brain cancer	8.1e-05	0.000163	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB2—brain cancer	8.05e-05	0.000162	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—brain cancer	7.97e-05	0.000161	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—brain cancer	7.95e-05	0.00016	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—brain cancer	7.77e-05	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—brain cancer	7.29e-05	0.000147	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—brain cancer	7.11e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CTNNB1—brain cancer	7.04e-05	0.000142	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—brain cancer	6.53e-05	0.000132	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—brain cancer	6.2e-05	0.000125	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—STAT3—brain cancer	6.14e-05	0.000124	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—brain cancer	5.7e-05	0.000115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—brain cancer	5.58e-05	0.000113	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—brain cancer	4.68e-05	9.45e-05	CbGpPWpGaD
